- Home
- Publications
- Publication Search
- Publication Details
Title
New Treatment Addressing the Pathogenesis of Psoriasis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 20, Pages 7488
Publisher
MDPI AG
Online
2020-10-14
DOI
10.3390/ijms21207488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis
- (2020) Karen M. Page et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
- (2019) Hervé Bachelez et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations
- (2019) Chihiro Imura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Psoriasis Pathogenesis and Treatment
- (2019) Adriana Rendon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Meta‐analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
- (2019) Han Witjes et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials
- (2019) A. Blauvelt et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
- (2019) Masutaka Furue et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dendritic cells: The driver of psoriasis
- (2019) Ao Wang et al. JOURNAL OF DERMATOLOGY
- Aryl Hydrocarbon Receptor in Cutaneous Vascular Endothelial Cells Restricts Psoriasis Development by Negatively Regulating Neutrophil Recruitment
- (2019) Zhenlai Zhu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- (2019) Farzan Solimani et al. Frontiers in Immunology
- Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment
- (2018) Ming Ji et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3)
- (2018) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17
- (2018) L.H. Eaton et al. BRITISH JOURNAL OF DERMATOLOGY
- A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test
- (2018) E.G. Kang et al. BRITISH JOURNAL OF DERMATOLOGY
- Scanning the Immunopathogenesis of Psoriasis
- (2018) Andrea Chiricozzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modeling clinical efficacy of the S1P receptor modulator ponesimod in psoriasis
- (2018) Andreas Krause et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- RNase 7 Strongly Promotes TLR9-Mediated DNA Sensing by Human Plasmacytoid Dendritic Cells
- (2018) Verena Kopfnagel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
- (2018) Vrajesh Bhaskarbhai Pandya et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis
- (2018) Lipeng Tang et al. Frontiers in Immunology
- Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1
- (2018) Mark Bell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: Pooled Analysis of Week 16 Data from 3 Randomized Controlled Trials
- (2018) A. Blauvelt et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long‐term safety and drug survival of acitretin in psoriasis: a retrospective observational study
- (2018) Leena Chularojanamontri et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- A Phase 2, Randomized Dose-Finding Study of Tapinarof (GSK2894512 Cream) for the Treatment of Plaque Psoriasis
- (2018) Kevin Robbins et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- More tolerance for dendritic cells in psoriasis
- (2017) Timo Buhl et al. EXPERIMENTAL DERMATOLOGY
- Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes
- (2017) Judilyn Fuentes-Duculan et al. EXPERIMENTAL DERMATOLOGY
- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study
- (2017) JianZhong Zhang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Pathogenesis of psoriasis and development of treatment
- (2017) Eisaku Ogawa et al. JOURNAL OF DERMATOLOGY
- Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10
- (2017) Alexandra Zanin-Zhorov et al. JOURNAL OF IMMUNOLOGY
- Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis
- (2017) Elisa Martini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
- (2017) Susan H. Smith et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
- (2017) Rajkumar Ganesan et al. mAbs
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Dendritic cell subsets
- (2017) Christophe Macri et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
- (2016) R. Flynn et al. BLOOD
- Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis
- (2016) Tomotaka Mabuchi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The role of epidermal sphingolipids in dermatologic diseases
- (2016) Sonia Borodzicz et al. Lipids in Health and Disease
- To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling
- (2016) Wee Siong Chew et al. PHARMACOLOGICAL RESEARCH
- Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation
- (2016) Tej Pratap Singh et al. Nature Communications
- Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
- (2016) Daniele D’Ambrosio et al. Therapeutic Advances in Chronic Disease
- Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
- (2016) Jonathan West et al. PLoS One
- Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation
- (2016) Hideaki Takagi et al. Scientific Reports
- Treating psoriasis with adalimumab
- (2016) Kenneth Gordon Therapeutics and Clinical Risk Management
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
- (2015) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
- (2015) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Secukinumab (AIN457) for the treatment of psoriasis
- (2015) Anna López-Ferrer et al. Expert Review of Clinical Immunology
- “Inflammatory skin march”: IL-1–mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events
- (2015) Keiichi Yamanaka et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Regulatory dendritic cells in autoimmunity: A comprehensive review
- (2015) Juan Liu et al. JOURNAL OF AUTOIMMUNITY
- An autoimmune “attack” on melanocytes triggers psoriasis and cellular hyperplasia
- (2015) James G. Krueger JOURNAL OF EXPERIMENTAL MEDICINE
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis
- (2015) Dorothea Terhorst et al. JOURNAL OF IMMUNOLOGY
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- The Aryl Hydrocarbon Receptor: Multitasking in the Immune System
- (2014) Brigitta Stockinger et al. Annual Review of Immunology
- Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA
- (2014) Roberto Lande et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: A role for interferon-alpha in dendritic cell activation by imiquimod
- (2014) Azumi Ueyama et al. JOURNAL OF DERMATOLOGY
- Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
- (2014) Andrea Vaclavkova et al. LANCET
- Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism
- (2014) Alexandra Zanin-Zhorov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human dendritic cell subsets
- (2013) Matthew Collin et al. IMMUNOLOGY
- Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis
- (2013) Katrin Schaper et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Th17 Cells Carrying TCR Recognizing Epidermal Autoantigen Induce Psoriasis-like Skin Inflammation
- (2013) S. Nishimoto et al. JOURNAL OF IMMUNOLOGY
- Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
- (2013) Gregory T. Kunkel et al. NATURE REVIEWS DRUG DISCOVERY
- Selective ROCK2 inhibition in focal cerebral ischemia
- (2013) Jeong Hyun Lee et al. Annals of Clinical and Translational Neurology
- Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
- (2012) Jason G. Cyster et al. Annual Review of Immunology
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study
- (2012) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Antimicrobial peptides in the pathogenesis of psoriasis
- (2012) Shin MORIZANE et al. JOURNAL OF DERMATOLOGY
- α-MSH-Stimulated Tolerogenic Dendritic Cells Induce Functional Regulatory T Cells and Ameliorate Ongoing Skin Inflammation
- (2012) Matteo Auriemma et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IFN-α Enhances IL-22 Receptor Expression in Keratinocytes: A Possible Role in the Development of Psoriasis
- (2012) Mikiko Tohyama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study
- (2012) S. Dogra et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity
- (2011) Wolf-Henning Boehncke et al. EXPERIMENTAL DERMATOLOGY
- Dendritic cell control of tolerogenic responses
- (2011) Santhakumar Manicassamy et al. IMMUNOLOGICAL REVIEWS
- IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway
- (2011) Kyung-Ah Cho et al. INTERNATIONAL IMMUNOLOGY
- Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses
- (2011) Anja Hänsel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands
- (2011) Shin Morizane et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation
- (2011) L. Piali et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis
- (2011) A Maza et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses
- (2010) Roberto Lande et al. Annals of the New York Academy of Sciences
- Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells
- (2010) Jean-Marie Ramirez et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Angiogenesis drives psoriasis pathogenesis
- (2010) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice
- (2010) Partha S. Biswas et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
- (2010) Andrea Chiricozzi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- 2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists
- (2010) Martin H. Bolli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling
- (2009) Stefanie Eyerich et al. JOURNAL OF CLINICAL INVESTIGATION
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
- (2009) Yuping Lai et al. TRENDS IN IMMUNOLOGY
- Sphingosine 1-Phosphate Restrains Insulin-Mediated Keratinocyte Proliferation via Inhibition of Akt through the S1P2 Receptor Subtype
- (2008) Melanie Schüppel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now